IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 330 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $204,000 | -23.0% | 3,455 | -20.2% | 0.01% | -11.1% |
| Q4 2019 | $265,000 | +5.2% | 4,332 | +0.9% | 0.01% | 0.0% |
| Q3 2019 | $252,000 | -12.2% | 4,294 | -3.7% | 0.01% | -10.0% |
| Q2 2019 | $287,000 | -17.3% | 4,460 | +2.2% | 0.01% | -16.7% |
| Q1 2019 | $347,000 | +23.0% | 4,365 | -16.7% | 0.01% | +9.1% |
| Q4 2018 | $282,000 | +0.4% | 5,239 | -3.2% | 0.01% | +10.0% |
| Q3 2018 | $281,000 | +20.6% | 5,412 | -3.0% | 0.01% | +11.1% |
| Q2 2018 | $233,000 | +2.2% | 5,579 | +5.9% | 0.01% | 0.0% |
| Q1 2018 | $228,000 | -7.3% | 5,268 | +9.0% | 0.01% | -10.0% |
| Q4 2017 | $246,000 | -5.0% | 4,835 | -5.9% | 0.01% | -9.1% |
| Q3 2017 | $259,000 | -7.2% | 5,136 | -6.0% | 0.01% | -8.3% |
| Q2 2017 | $279,000 | +39.5% | 5,463 | +9.9% | 0.01% | +20.0% |
| Q1 2017 | $200,000 | -16.3% | 4,969 | -0.6% | 0.01% | -16.7% |
| Q4 2016 | $239,000 | – | 4,997 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sicart Associates LLC | 367,360 | $14,768,000 | 10.67% |
| BB BIOTECH AG | 7,461,295 | $299,944,000 | 9.81% |
| TANAKA CAPITAL MANAGEMENT INC | 83,399 | $3,353,000 | 7.39% |
| DOWLING & YAHNKE LLC | 675,843 | $27,169,000 | 2.89% |
| Opus Point Partners Management, LLC | 78,900 | $3,172,000 | 2.35% |
| Motley Fool Asset Management LLC | 259,000 | $10,412,000 | 2.25% |
| ARK Investment Management | 127,563 | $5,128,000 | 1.48% |
| Motley Fool Wealth Management, LLC | 325,965 | $13,104,000 | 1.26% |
| PINNACLE ASSOCIATES LTD | 1,514,710 | $60,891,000 | 1.16% |
| Bellevue Group AG | 205,253 | $8,251,000 | 1.10% |